Share on LinkedInShare on LinkedIn

ARTICLE · 04 OCTOBER 2021

COVID-19 testing at home: new regulation to allow rapid antigen self-tests

Piper Alderman
Piper Alderman
Contributor
Piper Alderman

Piper Alderman

Helping shape the future of business in Australia with practical, commercial and cutting-edge legal...

View firm profile
Explore more from Piper Alderman

A new wave of COVID-19 rapid antigen self-tests, so sponsors must ensure appropriate systems are in place.

AustraliaCoronavirus (COVID-19)

With Australia expected to reach vaccination targets in mere weeks, the Therapeutic Goods Administration is reassessing its position on the supply of COVID-19 rapid antigen self-tests.

Change in regulation to allow supply of self-tests for home use

Aligning with the transition of Australia's national COVID-19 response, the Therapeutic Goods Administration (TGA) announced that they would make a new regulation on 1 October 2021 to allow companies to seek approval to legally supply COVID-19 rapid antigen self-tests for use at home in Australia after 1 November 2021. Currently, the supply of self-tests is prohibited under the Therapeutic Goods (Medical Devices – Excluded Purposes) Specification 2020 (Excluded Purposes Specification) for risk of under-reporting and reliability. However, with the national target of 70% double vaccination approaching quickly, the TGA is undertaking necessary work to allow the supply of self-tests in order to improve accessibility to

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from